Valerian medicinal rhizomes with roots tincture + Lily of the valley herb tincture (Tinctura rhizomatum cum radicibus Valerianae officinalis + tinctura herbae Convallariae)

Clinical and pharmacological group: & nbsp

Sedatives

Cardiac glycosides and non-glycosidic cardiotonic agents

Included in the formulation
  • Carneland
    drops n / az. 
  • Lily-Valerian drops
    drops inwards 
  • Lily-Valerian drops
    drops inwards 
  • АТХ:

    N.05.C.M   Other sleeping pills and sedatives

    Pharmacodynamics:

    Combined means.

    Valerians of medicinal rhizomes with roots of tincture

    In the rhizomes and roots of valerian contains essential oil with the main component - bornesteral ester with isovaleric acid, and free valerian acid, which has an antispasmodic effect.

    The drug reduces the excitability of the central nervous system, has an antispasmodic effect. Mediately, through neuroregulatory mechanisms, regulates heart activity and has a direct effect on automatism and the conduction system of the heart. Has a moderate choleretic effect.

    Lily of the valley herb tincture

    Phytopreparation in the form of lily of the valley herb tincture in the concentration of 100 g / l. Providing blocking effect on the transport of sodium potassium ATPase, and then increases the content of sodium ions in cardiac myocytes, calcium channels open, calcium enters into the cell interior.An increase in the concentration of sodium accelerates the release of calcium from the sarcoplasmic reticulum and increases its content in the cell, thereby inhibiting the troponin complex, which inhibits the interaction of actin and myosin. The strength and speed of contraction of the cardiac muscle increases regardless of the preliminary stretching of the myocardium - the systole is shortened, becoming energetically economical. Increased myocardial contractility contributes to an increase in the shock volume of the blood.

    Reduction of the end systolic and diastolic volumes of the heart together with an increase in myocardial tone reduces the size of the heart, reducing the need for myocardium in oxygen.

    Carries out a negative chronotropic action, reduces the increased sympathetic activity, increasing the sensitivity of cardiopulmonary baroreceptors. Strengthening the activity of the vagus nerve, has an antiarrhythmic effect due to the elongation of the refractory period and a decrease in the rate of impulses through the atrioventricular node. The effect is improved by direct action on atrioventricular node and sympatholytic effects.

    Pharmacokinetics:

    Not described.

    Indications:

    It is used to treat insomnia, spasms of the gastrointestinal tract. Used in the complex therapy with increased nervous excitability.

    V.F40-F48.F45.3   Somatoform dysfunction of the autonomic nervous system

    V.F40-F48.F48.0   Neurasthenia

    V.F50-F59.F51.2   Sleep and wakefulness disorder inorganic etiology

    Contraindications:

    Age to 12 years, myocarditis, endocarditis, pregnancy and lactation, individual intolerance.

    Carefully:

    Atrioventricular block I degree, hypertrophic subaortic stenosis, mitral stenosis, acute myocardial infarction, arteriovenous shunt, amyloidosis of the heart, pericardial tamponade, hypersensitivity.

    Pregnancy and lactation:

    Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.

    Dosing and Administration:

    Use in children

    1-12 drops, 1 drop per year of life.

    Adults

    Inside, 20 drops 2-3 times a day.

    The highest daily dose: 60 drops.

    The highest single dose: 20 drops.

    Side effects:

    Central and peripheral nervous system: rarely - drowsiness, dizziness.

    Digestive system: nausea, vomiting, constipation with prolonged use.

    Musculoskeletal system: muscle weakness.

    Allergic reactions.

    Overdose:

    Increased side effects.

    Treatment is symptomatic.

    Interaction:

    Catecholamines, diuretics, calcium preparations contribute to the risk of glycoside intoxication.

    Spironolactone, verapamil, nifedipine, quinidine increase the concentration of the drug in the blood plasma.

    Admission of antacids reduces the absorption of the drug.

    Inotropic effect increases with simultaneous use with riboflavin, thiamine chloride, pyridoxine, folic acid, methionine, inosine, phosphaden, anabolic steroids.

    Strengthens the effect of antispasmodics and sedatives.

    Special instructions:

    When taking the drug is not recommended driving and working with moving machinery.

    Instructions
    Up